Share

Press Releases

March 31, 2021
Zoetis Inc . (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, May 6, 2021. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Glenn David will review first quarter 2021 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live webcast by visiting the Zoetis website at http://investor.zoetis.com/events-presentations . Information on accessing and pre-registering for the webcast is available beginning today. A replay of the webcast will be made available on May 6, 2021. About Zoetis Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses in advancing care for animals. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines, diagnostics, technologies and services, including biodevices, genetic tests and ...
March 10, 2021
Only stand-alone animal health company to align its sustainability targets with United Nations’ Sustainable Development Goals Commitments made to advance veterinary education and access to care; invest in innovation to support sustainable livestock farming Joins RE 100 with commitment to achieve 100% Renewable Energy use by 2050 Zoetis Inc. (NYSE:ZTS) today announced its long-term sustainability goals, which build on the company’s purpose to nurture the world and humankind by advancing care for animals. Under the banner Driven to Care , Zoetis brings to life its specific commitments to Communities, Animals and the Planet, including support of 10 of the 17 United Nations’ Sustainable Development Goals (SDGs). With operations in 45 countries, Zoetis has the global reach and capabilities to champion a healthier, more sustainable future for all. “While purpose has been a driving factor for Zoetis throughout our history, formalizing our goals and commitments integrates sustainability as a ...
February 24, 2021
Zoetis Inc. (NYSE:ZTS) will participate in the Cowen 41 st Annual Health Care Conference on Monday, March 1, 2021. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. She is scheduled to present at 1:20 p.m. ET. Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations . A replay of the presentation will also be available on the Zoetis website at the conclusion of the event. About Zoetis Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses in advancing care for animals. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines, diagnostics, technologies and services, including biodevices, genetic tests and precision livestock farming. Zoetis serves veterinarians, livestock producers and people ...
February 22, 2021
Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Securities 2021 Animal Health Summit Virtual Forum on Thursday, Feb. 25, 2021. Glenn David, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 7:50 a.m. ET. Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations . A replay of the presentation will also be available on the Zoetis website at the conclusion of the event. About Zoetis Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses in advancing care for animals. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines, diagnostics, technologies and services, including biodevices, genetic tests and precision livestock farming. Zoetis ...
February 22, 2021
Solensia is the first injectable monoclonal antibody (mAb) licensed for alleviation of pain associated with osteoarthritis (OA) in cats Solensia works as a monthly treatment targeting Nerve Growth Factor (NGF), a key player in OA pain European Commission Marketing Authorization for a similar product in dogs, Librela®,was received in November 2020 Zoetis Inc. (NYSE:ZTS) today announced that the European Commission has granted the marketing authorization for Solensia ® (frunevetmab), a new feline osteoarthritis treatment to alleviate pain. Osteoarthritis in cats is a very prevalent condition 1 , existing in 40% of cats, and may generate pain and limit a cat’s comfort and quality of life if not treated. Solensia works differently from current treatment options by targeting Nerve Growth Factor (NGF), a key player in osteoarthritis (OA) pain. 1,2 It functions like naturally occurring antibodies, with minimal involvement of the liver or kidneys in their metabolism and elimination process, ...
February 16, 2021
For Fourth Quarter 2020, Zoetis Reports Revenue of $1.8 Billion, Growing 8%, and Net Income of $359 Million, or $0.75 per Diluted Share, on a Reported Basis Reports Adjusted Net Income of $438 Million, or Adjusted Diluted EPS of $0.91, for Fourth Quarter 2020 Delivers 9% Operational Growth in Revenue and 3% Operational Growth in Adjusted Net Income for Fourth Quarter 2020 For Full Year 2020, Zoetis Reports Revenue of $6.7 Billion, Growing 7%, and Net Income of $1.6 Billion, or $3.42 per Diluted Share, on a Reported Basis Reports Adjusted Net Income of $1.8 Billion, or Adjusted Diluted EPS of $3.85 for Full Year 2020 Delivers 9% Operational Growth in Revenue and 10% Operational Growth in Adjusted Net Income for Full Year 2020 Provides Full Year 2021 Revenue Guidance of $7.400 - $7.550 Billion, with Diluted EPS of $4.02 - $4.14 on a Reported Basis, or $4.36 - $4.46 on an Adjusted Basis Zoetis Inc . (NYSE: ZTS) today reported its financial results for the fourth quarter and full year ...
February 10, 2021
The Board of Directors of Zoetis Inc . (NYSE:ZTS) has declared a second quarter 2021 dividend payable to holders of the company’s common stock of $0.25 per share. The dividend is to be paid on Tuesday, June 1, 2021, to holders of record on Wednesday, April 21, 2021. About Zoetis Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and precision livestock farming. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2019, the company generated annual revenue of $6.3 billion with approximately 10,600 employees. For more information, visit www.zoetis.com . DISCLOSURE NOTICES Forward-Looking Statements: This ...
February 9, 2021
Zoetis Inc . (NYSE: ZTS), the global leader in animal health, today announced that it has been named one of America’s Best Midsize Employers by Forbes Magazine for the fifth time. “At Zoetis, our colleagues drive our success and shape our reputation as a top employer,” said Roxanne Lagano, Executive Vice President, Chief Human Resources Officer and Global Operations. “We continue to build a diverse and inclusive culture - based on our Core Beliefs – where everyone can thrive, both personally and professionally. We are proud to consistently be recognized by Forbes as one of America’s Best Midsize Employers, and we thank our colleagues for recommending Zoetis as a great place to work.” Forbes determined its America’s Best Employers list based on an independent survey among a sample of 50,000 American employees working for companies with at least 1,000 people in their U.S. operations. The willingness to recommend one's own employer was used as the most important factor in the assessment. ...
January 28, 2021
Joins the ranks of 767 major U.S. businesses that received top marks in the HRC Foundation’s Annual Assessment of LGBTQ Workplace Equality Zoetis Inc . (NYSE: ZTS) today announced that it received a score of 100 percent on the Human Rights Campaign Foundation’s 2021 Corporate Equality Index (CEI), the nation’s foremost benchmarking survey and report measuring corporate policies and practices related to LGBTQ workplace equality. This is the first time Zoetis participated in the CEI and the company’s first external recognition of its dedication to LGBTQ+ individuals. Strong Policies Promote an LGBTQ+-Friendly Workplace The high marks scored by Zoetis in the CEI reflect the company’s focus on Diversity, Equity and Inclusion (DE&I) , which includes strong policies and programs that promote an LGBTQ+-friendly workplace, including: Enhanced parental leave for all new parents in the U.S., including for adoptions, fathers and same sex partners; A new colleague resource group, Pride at ...